» Articles » PMID: 20669055

Assessment of Physical Process Conditions for Enhanced Production of Novel Glutaminase-free L-asparaginase from Pectobacterium Carotovorum MTCC 1428

Overview
Date 2010 Jul 30
PMID 20669055
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Statistically based experimental design was applied to maximize the production of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428. The effect of physical process parameters (initial pH of the medium, temperature, rpm of the shaking incubator, and inoculum size) on the production of L-asparaginase from P. carotovorum MTCC 1428 was studied using central composite design technique. The individual optimum levels of initial pH of the medium, temperature, rpm of shaking incubator, and inoculum size were found to be 6.90, 29.8 °C, 157 rpm, and 2.61% (v/v), respectively, for the production of L-asparaginase. After physical process parameters optimization, the production and productivity of L-asparaginase was enhanced by 26.39% (specific activity) and 10.19%, respectively. Maximization of L-asparaginase production was achieved at 12 h under optimal levels of physical process parameters in shake flask level.

Citing Articles

Rotation Disk Process to Assess the Influence of Metals and Voltage on the Growth of Biofilm.

Barry D, McGrath P Materials (Basel). 2017; 9(7).

PMID: 28773689 PMC: 5456865. DOI: 10.3390/ma9070568.


Mitigation of acrylamide by l-asparaginase from Bacillus subtilis KDPS1 and analysis of degradation products by HPLC and HPTLC.

Sanghvi G, Bhimani K, Vaishnav D, Oza T, Dave G, Kunjadia P Springerplus. 2016; 5:533.

PMID: 27186497 PMC: 4846603. DOI: 10.1186/s40064-016-2159-8.


Reduction of acrylamide level through blanching with treatment by an extremely thermostable L-asparaginase during French fries processing.

Zuo S, Zhang T, Jiang B, Mu W Extremophiles. 2015; 19(4):841-51.

PMID: 26077968 DOI: 10.1007/s00792-015-0763-0.


Studies on Deimmunization of Antileukaemic L-Asparaginase to have Reduced Clinical Immunogenicity--An in silico Approach.

Ramya L, Pulicherla K Pathol Oncol Res. 2015; 21(4):909-20.

PMID: 25740072 DOI: 10.1007/s12253-015-9912-0.